Global Self Injection Device Market Growth 2025-2031

Publication ID:

LPI07256022

Publication Date:

July 4, 2025

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Self Injection Device market size is predicted to grow from US$ 9780 million in 2025 to US$ 12940 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Market competition is not intense. Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly and Gerresheimer, etc. are the leaders of the industry, with about 60% market shares.
Europe is the largest consumption place, with a consumption market share nearly 42%. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.
The 鈥淪elf Injection Device Industry Forecast鈥� looks at past sales and reviews total world Self Injection Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Self Injection Device sales for 2025 through 2031. With Self Injection Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Self Injection Device industry.
This Insight Report provides a comprehensive analysis of the global Self Injection Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Self Injection Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Self Injection Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Self Injection Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Self Injection Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Self Injection Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Reusable Self Injection Device
Disposable Self Injection Device
Segmentation by Application:
Insulin Injection
Epinephrine Injection
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier
Key Questions Addressed in this Report
What is the 10-year outlook for the global Self Injection Device market?
What factors are driving Self Injection Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Self Injection Device market opportunities vary by end market size?
How does Self Injection Device break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Self Injection Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Self Injection Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Self Injection Device by Country/Region, 2020, 2024 & 2031
2.2 Self Injection Device Segment by Type
2.2.1 Reusable Self Injection Device
2.2.2 Disposable Self Injection Device
2.3 Self Injection Device Sales by Type
2.3.1 Global Self Injection Device Sales Market Share by Type (2020-2025)
2.3.2 Global Self Injection Device Revenue and Market Share by Type (2020-2025)
2.3.3 Global Self Injection Device Sale Price by Type (2020-2025)
2.4 Self Injection Device Segment by Application
2.4.1 Insulin Injection
2.4.2 Epinephrine Injection
2.4.3 Others
2.5 Self Injection Device Sales by Application
2.5.1 Global Self Injection Device Sale Market Share by Application (2020-2025)
2.5.2 Global Self Injection Device Revenue and Market Share by Application (2020-2025)
2.5.3 Global Self Injection Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Self Injection Device Breakdown Data by Company
3.1.1 Global Self Injection Device Annual Sales by Company (2020-2025)
3.1.2 Global Self Injection Device Sales Market Share by Company (2020-2025)
3.2 Global Self Injection Device Annual Revenue by Company (2020-2025)
3.2.1 Global Self Injection Device Revenue by Company (2020-2025)
3.2.2 Global Self Injection Device Revenue Market Share by Company (2020-2025)
3.3 Global Self Injection Device Sale Price by Company
3.4 Key Manufacturers Self Injection Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Self Injection Device Product Location Distribution
3.4.2 Players Self Injection Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Self Injection Device by Geographic Region
4.1 World Historic Self Injection Device Market Size by Geographic Region (2020-2025)
4.1.1 Global Self Injection Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Self Injection Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Self Injection Device Market Size by Country/Region (2020-2025)
4.2.1 Global Self Injection Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Self Injection Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Self Injection Device Sales Growth
4.4 APAC Self Injection Device Sales Growth
4.5 Europe Self Injection Device Sales Growth
4.6 Middle East & Africa Self Injection Device Sales Growth
5 Americas
5.1 Americas Self Injection Device Sales by Country
5.1.1 Americas Self Injection Device Sales by Country (2020-2025)
5.1.2 Americas Self Injection Device Revenue by Country (2020-2025)
5.2 Americas Self Injection Device Sales by Type (2020-2025)
5.3 Americas Self Injection Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Self Injection Device Sales by Region
6.1.1 APAC Self Injection Device Sales by Region (2020-2025)
6.1.2 APAC Self Injection Device Revenue by Region (2020-2025)
6.2 APAC Self Injection Device Sales by Type (2020-2025)
6.3 APAC Self Injection Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Self Injection Device by Country
7.1.1 Europe Self Injection Device Sales by Country (2020-2025)
7.1.2 Europe Self Injection Device Revenue by Country (2020-2025)
7.2 Europe Self Injection Device Sales by Type (2020-2025)
7.3 Europe Self Injection Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Self Injection Device by Country
8.1.1 Middle East & Africa Self Injection Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Self Injection Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Self Injection Device Sales by Type (2020-2025)
8.3 Middle East & Africa Self Injection Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Self Injection Device
10.3 Manufacturing Process Analysis of Self Injection Device
10.4 Industry Chain Structure of Self Injection Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Self Injection Device Distributors
11.3 Self Injection Device Customer
12 World Forecast Review for Self Injection Device by Geographic Region
12.1 Global Self Injection Device Market Size Forecast by Region
12.1.1 Global Self Injection Device Forecast by Region (2026-2031)
12.1.2 Global Self Injection Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Self Injection Device Forecast by Type (2026-2031)
12.7 Global Self Injection Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Self Injection Device Product Portfolios and Specifications
13.1.3 Novo Nordisk Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Self Injection Device Product Portfolios and Specifications
13.2.3 Mylan Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Self Injection Device Product Portfolios and Specifications
13.3.3 Pfizer Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Self Injection Device Product Portfolios and Specifications
13.4.3 Sanofi Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Self Injection Device Product Portfolios and Specifications
13.5.3 BD Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Self Injection Device Product Portfolios and Specifications
13.6.3 Eli Lilly Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 Gerresheimer
13.7.1 Gerresheimer Company Information
13.7.2 Gerresheimer Self Injection Device Product Portfolios and Specifications
13.7.3 Gerresheimer Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Gerresheimer Main Business Overview
13.7.5 Gerresheimer Latest Developments
13.8 Dongbao
13.8.1 Dongbao Company Information
13.8.2 Dongbao Self Injection Device Product Portfolios and Specifications
13.8.3 Dongbao Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Dongbao Main Business Overview
13.8.5 Dongbao Latest Developments
13.9 Ypsomed
13.9.1 Ypsomed Company Information
13.9.2 Ypsomed Self Injection Device Product Portfolios and Specifications
13.9.3 Ypsomed Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Ypsomed Main Business Overview
13.9.5 Ypsomed Latest Developments
13.10 Owen Mumford
13.10.1 Owen Mumford Company Information
13.10.2 Owen Mumford Self Injection Device Product Portfolios and Specifications
13.10.3 Owen Mumford Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Owen Mumford Main Business Overview
13.10.5 Owen Mumford Latest Developments
13.11 Antares Pharma
13.11.1 Antares Pharma Company Information
13.11.2 Antares Pharma Self Injection Device Product Portfolios and Specifications
13.11.3 Antares Pharma Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Antares Pharma Main Business Overview
13.11.5 Antares Pharma Latest Developments
13.12 Haselmeier
13.12.1 Haselmeier Company Information
13.12.2 Haselmeier Self Injection Device Product Portfolios and Specifications
13.12.3 Haselmeier Self Injection Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Haselmeier Main Business Overview
13.12.5 Haselmeier Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂